Purified rat CD4 T cells were activated in vitro, by the polyclonal mitogen Concanavalin A (Con A) or by mixed lymphocyte reaction (MLR), in the presence or absence of the glucocorticoid dexamethasone (DEX). They were then expanded in IL-2 and subsequently restimulated, this time in the absence of the hormone. The results indicate that the exposure of the cells to DEX in the primary stimulation changed the cytokine synthesis induced by the secondary stimulation. IL-4 production was increased by the pretreatment whereas synthesis of IFN-y was diminished. Addition of DEX in the second activation suppressed all cytokine production. In brief, the transient presence of glucocorticoids in the culture induces a change in the pattern of cytokine production but the continuous presence causes inhibition of cytokine synthesis. Further studies in which IL-4 was used together with DEX showed that the cytokine potentiated the effect of the hormone.
INTRODUCTION
Understanding the influence of glucocorticoids on the immune system is important for two reasons: first, corticosteroids are used as immunosuppressive and anti-inflammatory agents in organ transplantation and in the treatment of many autoimmune and inflammatory diseases. Second, it is not commonly recognised that, in addition to their pharmacological actions, these steroids are natural hormones that play an essential physiological role in the regulation of the immune system. Release of endogenous glucocorticoids protects us against our own defense mechanisms by preventing an excessive immunological reaction (Munck et al., 1984) . During the course of an immune response corticoid secretion from the adrenal glands is increased and this mechanism limits the magnitude of the inflammatory reaction to an immunogenic stimulus (Besedovsky et al., 1975) . Following activation of the immune system several soluble factors that activate the neuroendocrine system are released (Besedovsky et al,., 1981) . Partial failures in this interaction between the immune and neuroendocrine systems contribute to the pathogenesis of certain autoimmune and inflammatory experimental diseases like thyroiditis, arthritis and experimental allergic encephalomyelitis (EAE) (Kroemer et al., 1988; MacPhee et al., 1989; Sternberg et al., 1989; Mason et al., 1990) . There are also evidences that patients with rheumatoid arthritis show a defective regulation of corticosteroids production (Chikanza et al., 1992) .
Our interest in the role of corticosteroids in the regulation of the immune response originated from the study of EAE in Lewis rats. EAE is an animal model of autoimmune disease, similar to multiple sclerosis, that can be induced in the appropriate animal strains after immunization with myelin basic protein (MBP) in complete Freund's adjuvant. EAE in Lewis rats is a monophasic disease characterized by a single episode of paralysis, caused by the action of CD4 T lymphocytes on the nervous system, followed by spontaneous recovery. Animals that have recovered are refractory to attempts to induce further episodes of disease (Zamvil and Steinman, 1990) . The mechanisms responsible for the spontaneous recovery and the maintenance of the refractory state, although object of intense research, are not completely understood. One mechanism that controls the course of EAE is neuroendocrine-mediated immunoregulation. It has been shown that endogenously produced corticosterone plays an essential role in the recovery of rats from EAE: Unlike normal rats, adrenalectomized animals do not recover spontaneously but instead develop a progressive paralysis with a fatal consequence.
If these animals are administered corticosterone, they recover and become refractory to the development of new episodes of disease (Levine et al., 1980; MacPhee et al., 1989) . The spontaneous recovery of rats from EAE probably occurs because corticosteroids, which are found at high levels in the sera of paralyzed animals, acutely depress the autoimmune response through their immunosuppressive effects. However, animals that have recovered from disease have normal serum steroid levels indicating that corticosteroids are not directly responsible for the maintenance of the refractory phase of the disease. These findings suggest that, in addition to their acute immunosuppressive actions, corticosteroids may display a more subtle and long-lasting effect on the immune response. As EAE elicited by MBP in the Lewis rat is a cell-mediated disease involving T cells that produce IL-2 and IFN-y (Sedgwick et al., 1989) , the refractory phase of EAE could in principle be explained if it could be shown that corticosteroids inhibit proinflammatory cytokine production and induce the production of cytokines that inhibit cellmediated immune responses (Mason, 1991) .
Corticosteroids inhibit the production of many interleukins during T-cell activation (Gillis et al., 1979; Snyder and Unanue, 1982; Arya et al., 1984; Beutler et al., 1986; Waage et al., 1990; Wu et al., 1991) . The question we want to answer in the experiments here described is whether in situations where corticosteroid concentration is increased, therapeutically or physiologically, there are any long-term effects produced by the hormone. To elucidate the answer, we have used a similar approach to that employed by others to study the effects of the presence of some cytokines on the development of the immune response (Swain et al., 1988 (Wu et al., 1991; Byron et al., 1992; Ramrez et al., 1996) , a different result was obtained when DEX-treated cells were activated a second time in the absence of the hormone (Ramfrez et al., 1996) . This protocol, shown in Figure 1 , was designed to examine whether corticosteroid primes the cells to produce a particular cytokine response on restimulation and also to mimic to a degree the in vivo situation in EAE, where only a transient increase in blood corticosterone levels occurs.
Measurements were made of the levels of IL-4 mRNA from cells cultured in the presence or absence of DEX by RT-PCR analysis. Figure 2 shows that CD4 T cells cultured with the steroid during the primary activation and expansion periods (lanes 7-9) expressed approximately tenfold higher levels of IL-4 mRNA after secondary activation than cells cultured in the absence of DEX (lanes 1-3) . In a previous paper, it was shown that mRNA for IL-10 and IL-13 showed the same temporal variation as that for IL-4 (Ramirez et al., 1996) . Similar results to the one shown in Figure 2 are obtained when cells are in the presence of the glucocorticoid only during the expansion phase (data not shown): It is evident that to induce an increase in IL-4 mRNA, it is not necessary to include the hormone in the culture from the primary activation to the expansion phase.
To exclude the possibility that the mechanism of IL-4 mRNA induction shown in Figure 2 is 
FIGURE
Experimental design to analyze long-lasting effects of dexamethasone on cytokine production. T-cell activation was performed by Con A or MLR. To analyze DEX effects on Con A-activated cells the following protocol was adopted: CD4 T cells (106/ml) were cultured with accessory cells (106/ml) and incubated with 5/g/ml Con A in the presence of different combinations of DEX (10 M) and rIL-4 (500 U/ml) for 3 days (primary activation phase). The cells were washed and cultured (105/ml) for 4 days in the presence of rIL-2 (50 U/ml), some cultures were supplemented with different combinations of DEX (10 -8 M) and rIL-4 (500 U/ml) (expansion phase). Cells were recovered and restimulated with 5 /xg/ml of Con A in the presence of accessory cells and in the absence of DEX and rIL-4 (secondary activation phase). After 24 hr of the secondary activation, RNA was extracted from the different cell cultures and supernatants were removed for cytokine analysis. To analyze DEX effects on MLR, the protocol was identical to the one described before but cell densities were 2.5 X 106 responder cells/ml and 2.5 106 stimulator cells/ml on the primary activation. During the expansion phase, cells were cultured at 106 cells/ml. In the secondary activation, stimulator cells densities were 2.5 106 cells/ml, but responder cell densities was reduced to 106 cells/ml. Supernatants were removed at 48 hr of culture. In the previous experiment (Figure 2 ), IL-4 production was analyzed at the level of RNA due to the lack of an assay for rat IL-4 protein. An anti-rat IL-4 mAb, which blocks the biological activity of rat IL-4, was obtained recently in our laboratory. It is now possible to quantitate the IL-4 protein in different supernatants testing their capacity to induce the upregulation of MHC class II expression on purified B cells. To assess the specificity of the bioassay, the anti-IL-4 mAb OX-81 is added to the cultures (Ramfrez et al., 1996) . The levels of IL-4 protein in the supernatants from DEXtreated CD4 T-cell cultures were assayed and this is shown in Figure 3 . Cells treated with DEX during the primary activation and expansion stages produce more IL-4 after secondary activation than control cultures not treated with DEX (undetectable levels). In this experiment, IL-4-treated cells were included as a positive control for the assay, because it is known that IL-4 upregulates its own production (Swain et al., 1990) . FIGURE 2 Dexamethasone increases IL-4 mRNA levels in Con A-activated CD4 T cells after secondary activation. Purified rat CD4 T cells from LN were activated (106/ml) with Con A (5 #g/ml) in the presence of accessory cells. After a 3-day activation period, the cells were maintained in rIL-2 for 4 days. Cells were cultured with different combinations of DEX and rIL-4 during the primary activation and expansion periods as described in Materials and Methods (see Fig. 1 ). Cells were reactivated with Con A in the presence of accessory cells. After a 24-hr activation period, total cellular RNA was extracted and analysis of IL-4 and/3-actin mRNA levels were performed by the RT-PCR technique as described in Materials and Methods. Three tenfold dilutions from each cDNA sample were amplified by PCR (neat, 1/10, and 1/100). In the gel electrophoresis, lanes 1-3 represent amplified products from increasing dilutions of cDNA from control treatment cells, lanes 4-6 amplified products from cDNA from control treatment cells treated during the secondary activation with 10 M DEX, lanes 7-9 amplified products from cDNA from cells cultured during the primary activation and expansion phases in the presence of 10 -8 M DEX, and lanes 10-12 amplified products from cDNA from cells cultured during the primary activation, expansion phases and secondary activation in the presence of 10-SM DEX. these experiments is in contrast to data published by others (Swain et al., 1990) . This point will be discussed further later in this paper. For TNF production, it was observed that the presence of DEX in both the primary activation and IL-2 expansion phases decreased the production of this cytokine (66% inhibition) (Figure 4) . In contrast to the effects observed on IFN-y production, the addition of rIL-4 to the cultures during the primary activation and expansion phases showed an inhibitory effect on TNF synthesis (71% inhibition), and this effect was stronger when the rIL-4 was supplemented with DEX (86% inhibition).
IL-2 levels were also determined for the same cultures as those assayed for IFN-y and TNF ( Figure  4 ). DEX treatment did not produce a marked inhibitory effect on IL-2 synthesis in the second stimulation (24% inhibition). The presence of rIL-4 during the primary activation resulted in inhibition of IL-2 production on secondary stimulation (63% inhibition) and this effect was enhanced in the presence of DEX (98% inhibition).
The Presence of Dexamethasone During Primary T-Cell Activation in a MLR Increases IL-4 Production in CD4 T Cells After Secondary Stimulation in the Absence of the Hormone
In the previous experiments, cytokine production was analyzed after Con A activation. It was important to show that the effect of glucocorticoid on cytokine production is independent of the mechanism of T-cell activation. To address this point, analyses of cytokine production were made after MLR activation following the same protocol employed for Con A activation (Figure 1 ). Figure 5 shows that DEX-treated cells produce more IL-4 than untreated cells (no IL-4 was detected), but IL-4 is a better inducer of IL-4 than DEX. DEX and IL-4 added separately or together during the primary MLR reduce strikingly IFN-T production by CD4 T cells on Culture conditions during primary activation and expansion phases FIGURE 4 The effects of dexamethasone and IL-4 on IFN-y, IL-2, and TNF synthesis by restimulated CD4 T cells. Purified rat CD4 lymphocytes from LNC and thoracic duct were taken through the three-step activation process depicted in Fig. 1 last idea harmonizes well with the physiology of glucocorticoids, controlling the magnitude of the protective responses of the body. Steroids will be released by the adrenal glands during an immune response when the mediators of inflammation reach certain dangerous levels. These hormones have a direct effect on the synthesis of these mediators of inflammation but also may have some indirect and long-lasting effect inducing the synthesis of antiinflammatory cytokines. The data support the hypothesis outlined in the Introduction that the autoregulation of EAE is induced by endogenously produced glucocorticoids (Mason, 1991) . This hypothesis provides an explanation for the recovery and refractory periods, but a detailed analysis of the cytokines produced during the different phases of EAE, and how endogenous glucocorticoids affect this synthesis, is necessary to demonstrate it. In other systems, a similar effect on cytokine production induced by glucocorticoids has been observed in vivo (Daynes and Araneo, 1989; Daynes et al., 1990 ).
Our demonstration of the modulation of cytokine gene expression by corticosteroids has a number of more general implications. It may be anticipated that endogenous production of these hormones in response to environmental stress may interfere with the immune response required to control infections that normally elicit a protective Thl type reaction and there are published data to support this suggestion (Sheridan et al., 1991; Moynihan et al., 1994) . Such an interaction between the neuroendocrine system and the immune system may, for example, help to explain the prevalence of mycobacterial infections in areas of poverty and malnutrition. Such a possibility has wide implications for the control of such diseases. In addition, our data provide an explanation for how relatively short courses of high-dose steroids used pharmacologically, for example, to control an episode of renal allograft rejection, can apparently have beneficial effects that persist after reduction of the dose of the drug.
IL-4 was included in the experiments as a positive control for the generation of a Th2 cytokine pattern in vitro as already has been described (Swain et al., 1990) . As expected, we found very potent IL-4 production in the second stimulation and striking inhibition of TNF and IL-2 synthesis in these secondary cultures. However, we did not observe any inhibition of IFN-y production in Con A-activated cells (Figure 4 ). Increasing the amount of IL-4 in the culture provokes inhibition of IFN-y production in the secondary activation, but this inhibition was never complete (data not shown). In contrast, a strong inhibition of IFN-y production was observed in MLRactivated cells, which indicates differences in the activation signal between the two protocols.
In summary, the present work suggests that corticosteroids not only have a direct anti-inflammatory effect (acute effect), but also promote a long-lasting one, increasing the production of anti-inflammatory interleukins and decreasing the synthesis of proinflammatory cytokines.
MATERIALS AND METHODS

Animals
Lewis, DA, and PVG.RT1 rats were from the specific pathogen-free unit of the MRC Cellular Immunology Unit (Oxford, UK).
Rat Recombinant Interleukins and Other Reagents
Tissue-culture supernatants containing either rat rIL-2 or rat rlL-4 were obtained from stably transfected CHO cell lines, using the rat IL-2 or rat IL-4 cDNA sequences (McKnight and Classon, 1992) . Rat rIFN-y was kindly provided by P. van 
Antibodies
Monoclonal antibodies used were W3/13 (anti-rat CD43) (Williams et al., 1977) ; MRC-OX6 (anti-rat MHC class II) (McMaster and Williams, 1979) ; MRC-OX8 (anti-rat CD8) (Brideau et al., 1980) ; MRC-OX12 (anti-rat t< chain) (Hunt and Fowler, 1981) , MRC-OX39 (anti-rat IL-2Ro chain) (Paterson et al., 1987) , and MRC-OX81 (anti-rat IL-4) (Ramfrez et al., 1996) were from the MRC Cellular Immunology Unit; DB-1 (mouse anti-rat IFN-y (Van der Meide et al., 1986) (Gowans and Knight, 1964) .
Isolation of Subsets of Lymphocytes
Subpopulations of TDL, LNC, and splenocytes were purified by negative selection using the rosetting technique (Mason et al., 1987 To analyze long-lasting effects of GCs on Con A and MLR activation, the protocol used is shown in Figure  1 . CD4 T lymphocytes from LN or thoracic duct were stimulated with Con A in the presence of preirradiated T-cell-depleted splenocytes as accessory cells (Con A activation) or irradiated allogenic splenocytes (MLR activation) in RPMI culture medium supplemented with FCS,/-ME, and antibiotics. After 3 days in culture (primary activation), the lymphocytes were cultured in the presence of 50 U/ml of rat rIL-2 (expansion phase). Four days later, the cells were centrifuged over a Ficoll-Hypaque density gradient, washed and restimulated with Con A in the presence of irradiated T-cell-depleted splenocytes (secondary Con A activation) or irradiated allogenic splenocytes (secondary MLR activation), and then tested for cytokine production. As indicated in the text and in Figure 1 , some cultures were maintained in different combinations of DEX (10-SM) and rat (500 U/ml) during the primary activation or expansion phase. In the remaining text of this paper, the three phases of this protocol will be referred to as the primary activation phase, the expansion phase, and the secondary activation phase, respectively. The reaction buffer and the primer sequences for rat IL-4 and /3-actin have been previously described (McKnight et al., 1991) . These primers were designed to amplify cDNA fragments of 378 bp for IL-4 and 607 bp for /3-actin. The amplified products were visualized by ethidium bromide staining after agarose-gel electrophoresis. In order to assure that the PCR products were not being assayed on the plateau of the amplification curve, all cDNA samples were amplified at 3 tenfold dilutions. This procedure allowed semiquantitative comparisons to be made of the levels of cDNA present in different samples and ensured that the /3-actin controls were also not run under saturating (plateau) conditions. Cytokine Assays IFN-y was measured by a specific ELISA using the mAb DB-1 (mouse anti-rat IFN-y) and a rabbit antimouse IFN-y antiserum that cross-reacts with rat IFN-y. Rat rIFN-y was used as a standard. IL-2 production was measured using the mouse IL-2-dependent cell line CTLL-2 (Gillis et al., 1978) . Human rIL-2 was used as a standard. The CTLL-2 cell line responds to rat IL-2 but not to rat rIL-4.
TNF production was measured using TNF-sensitive actinomycin-D-treated murine L929 fibroblasts (Aggarwal et al., 1984) . To assess the specificity of the assay, a polyclonal rabbit anti-rat TNF was used and all the activity contained in the supernatants was blocked.
